Exploring the roles and clinical potential of exosome-derived non-coding RNAs in glioma

Non-coding accounts for 98 %-99 % of the human genome and performs many essential regulatory functions in eukaryotes, involved in cancer development and development. Non-coding RNAs are abundantly enriched in exosomes, which play a biological role as vectors. Some biofunctional non-coding RNAs are s...

Full description

Saved in:
Bibliographic Details
Main Authors: Peng Jin, Xue Bai
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:IBRO Neuroscience Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667242125000156
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849334804590362624
author Peng Jin
Xue Bai
author_facet Peng Jin
Xue Bai
author_sort Peng Jin
collection DOAJ
description Non-coding accounts for 98 %-99 % of the human genome and performs many essential regulatory functions in eukaryotes, involved in cancer development and development. Non-coding RNAs are abundantly enriched in exosomes, which play a biological role as vectors. Some biofunctional non-coding RNAs are specifically designed as exosomes for the treatment of cancers such as glioma. Glioma is one of the most common primary tumors within the skull and has varying degrees of malignancy and histologic subtypes of grades I-IV. Gliomas are characterized by high malignancy and an abundant blood supply due to rapid cell proliferation and vascularization, often with a poor prognosis. Exosomal non-coding RNAs can be involved in the tumorigenesis process of glioma from multiple directions, such as angiogenesis, tumor proliferation, metastatic invasion, immune evasion, apoptosis, and autophagy. Therefore, non-coding RNAs in exosomes are suitable as markers or therapeutic targets for early diagnosis of diseases and for predicting the prognosis of a variety of diseases. Regulating exosome production and the level of exosomal non-coding RNA expression may be a new approach to prevent or eliminate glioma. In this review, we review the origin and characteristics of exosomal non-coding RNAs, and introduce the functional studies of exosomal non-coding RNAs in glioma and their potential clinical applications, in order to broaden new ideas for the treatment of glioma.
format Article
id doaj-art-c33733eccfaf401bb3a47d8678c74358
institution Kabale University
issn 2667-2421
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series IBRO Neuroscience Reports
spelling doaj-art-c33733eccfaf401bb3a47d8678c743582025-08-20T03:45:28ZengElsevierIBRO Neuroscience Reports2667-24212025-06-011832333710.1016/j.ibneur.2025.01.015Exploring the roles and clinical potential of exosome-derived non-coding RNAs in gliomaPeng Jin0Xue Bai1Department of Neurosurgery, Hulunbuir People’s Hospital, Hulunbuir, Inner Mongolia Autonomous Region 021000, ChinaDepartment of Intensive Care Unit, Hulunbuir People’s Hospital, No. 20, Shengli Street, Hailar District, Hulunbuir, Inner Mongolia Autonomous Region 021000, China; Corresponding author.Non-coding accounts for 98 %-99 % of the human genome and performs many essential regulatory functions in eukaryotes, involved in cancer development and development. Non-coding RNAs are abundantly enriched in exosomes, which play a biological role as vectors. Some biofunctional non-coding RNAs are specifically designed as exosomes for the treatment of cancers such as glioma. Glioma is one of the most common primary tumors within the skull and has varying degrees of malignancy and histologic subtypes of grades I-IV. Gliomas are characterized by high malignancy and an abundant blood supply due to rapid cell proliferation and vascularization, often with a poor prognosis. Exosomal non-coding RNAs can be involved in the tumorigenesis process of glioma from multiple directions, such as angiogenesis, tumor proliferation, metastatic invasion, immune evasion, apoptosis, and autophagy. Therefore, non-coding RNAs in exosomes are suitable as markers or therapeutic targets for early diagnosis of diseases and for predicting the prognosis of a variety of diseases. Regulating exosome production and the level of exosomal non-coding RNA expression may be a new approach to prevent or eliminate glioma. In this review, we review the origin and characteristics of exosomal non-coding RNAs, and introduce the functional studies of exosomal non-coding RNAs in glioma and their potential clinical applications, in order to broaden new ideas for the treatment of glioma.http://www.sciencedirect.com/science/article/pii/S2667242125000156RNAExosomesGliomaBiomarkersSignaling transduction
spellingShingle Peng Jin
Xue Bai
Exploring the roles and clinical potential of exosome-derived non-coding RNAs in glioma
IBRO Neuroscience Reports
RNA
Exosomes
Glioma
Biomarkers
Signaling transduction
title Exploring the roles and clinical potential of exosome-derived non-coding RNAs in glioma
title_full Exploring the roles and clinical potential of exosome-derived non-coding RNAs in glioma
title_fullStr Exploring the roles and clinical potential of exosome-derived non-coding RNAs in glioma
title_full_unstemmed Exploring the roles and clinical potential of exosome-derived non-coding RNAs in glioma
title_short Exploring the roles and clinical potential of exosome-derived non-coding RNAs in glioma
title_sort exploring the roles and clinical potential of exosome derived non coding rnas in glioma
topic RNA
Exosomes
Glioma
Biomarkers
Signaling transduction
url http://www.sciencedirect.com/science/article/pii/S2667242125000156
work_keys_str_mv AT pengjin exploringtherolesandclinicalpotentialofexosomederivednoncodingrnasinglioma
AT xuebai exploringtherolesandclinicalpotentialofexosomederivednoncodingrnasinglioma